787585-30-2 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-Fluoro-4-methylphenyl)-2-methylpropan-2-ol is used as a potent analgesic for the treatment of severe pain. Its high efficacy in pain management makes it a valuable component in the pharmaceutical industry, particularly for conditions that require strong pain relief.
Used in Anesthesia:
In the field of anesthesia, 1-(3-Fluoro-4-methylphenyl)-2-methylpropan-2-ol is utilized as a component in the induction and maintenance of anesthesia during surgical procedures. Its ability to suppress pain pathways in the central nervous system makes it a crucial element in ensuring patient comfort and minimizing pain during surgery.
Used in Pain Management for Chronic Conditions:
1-(3-Fluoro-4-methylphenyl)-2-methylpropan-2-ol is also used in the management of chronic pain conditions, such as cancer pain, where the need for strong analgesics is essential. Its potency allows for effective pain relief in patients suffering from severe and persistent pain.
Used in Research and Development:
Fentanyl, as 1-(3-Fluoro-4-methylphenyl)-2-methylpropan-2-ol, is employed in research and development for the study of opioid receptors and the development of new pain management strategies. Its interaction with the mu-opioid receptor provides valuable insights into the mechanisms of pain relief and the potential for developing alternative treatments with reduced risks of abuse and addiction.
Check Digit Verification of cas no
The CAS Registry Mumber 787585-30-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,7,5,8 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 787585-30:
(8*7)+(7*8)+(6*7)+(5*5)+(4*8)+(3*5)+(2*3)+(1*0)=232
232 % 10 = 2
So 787585-30-2 is a valid CAS Registry Number.
787585-30-2Relevant academic research and scientific papers
CaSR antagonist
-
Page/Page column 40; 71-72, (2010/02/10)
A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A compound having a calcium-sensing receptor antagonistic action, a pharmaceutical composition comprising the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis are provided.
